Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,290 | 11 | 83.4% |
| Travel and Lodging | $912.77 | 3 | 7.4% |
| Education | $657.00 | 1 | 5.3% |
| Food and Beverage | $476.56 | 7 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $5,071 | 9 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $2,475 | 5 | $0 (2018) |
| SANOFI PASTEUR INC. | $1,448 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $980.00 | 1 | $0 (2024) |
| SANOFI US SERVICES INC. | $724.00 | 1 | $0 (2022) |
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $657.00 | 1 | $0 (2020) |
| Vertex Pharmaceuticals Incorporated | $433.33 | 1 | $0 (2021) |
| Vifor (International) Ltd. | $400.00 | 1 | $0 (2020) |
| Calliditas Therapeutics US Inc. | $100.64 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $48.06 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $980.00 | 1 | AstraZeneca Pharmaceuticals LP ($980.00) |
| 2023 | $100.64 | 1 | Calliditas Therapeutics US Inc. ($100.64) |
| 2022 | $2,172 | 2 | SANOFI PASTEUR INC. ($1,448) |
| 2021 | $433.33 | 1 | Vertex Pharmaceuticals Incorporated ($433.33) |
| 2020 | $1,057 | 2 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($657.00) |
| 2019 | $48.06 | 1 | Alexion Pharmaceuticals, Inc. ($48.06) |
| 2018 | $6,671 | 10 | GENZYME CORPORATION ($5,071) |
| 2017 | $875.00 | 4 | E.R. Squibb & Sons, L.L.C. ($875.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $980.00 | General |
| 03/21/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $100.64 | General |
| Category: Nephrology | ||||||
| 11/21/2022 | SANOFI PASTEUR INC. | MENQUADFI (Biological) | Consulting Fee | Cash or cash equivalent | $1,448.00 | General |
| Category: Vaccines | ||||||
| 11/02/2022 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $724.00 | General |
| 08/23/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $433.33 | General |
| 10/28/2020 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Education | In-kind items and services | $657.00 | General |
| Category: GENE THERAPY | ||||||
| 06/09/2020 | Vifor (International) Ltd. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 03/08/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $48.06 | General |
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Consulting Fee | Cash or cash equivalent | $3,830.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Travel and Lodging | In-kind items and services | $626.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Travel and Lodging | In-kind items and services | $258.77 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $69.96 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2018 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Immunology | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: Immunology | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: Immunology | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 20 | $9,200 | $2,795 |
| 2022 | 1 | 17 | 37 | $13,947 | $4,812 |
| 2021 | 1 | 15 | 40 | $13,240 | $5,563 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 20 | $9,200 | $2,795 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 37 | $13,947 | $4,812 | 34.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 40 | $13,240 | $5,563 | 42.0% |
About Dr. Vikas Dharnidharka, MD
Dr. Vikas Dharnidharka, MD is a Pediatrics healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619915246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikas Dharnidharka, MD has received a total of $12,337 in payments from pharmaceutical and medical device companies, with $980.00 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($10,290).
As a Medicare-enrolled provider, Dharnidharka has provided services to 44 Medicare beneficiaries, totaling 97 services with total Medicare billing of $13,169. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Nephrology, Pediatric Nephrology
- Location New Brunswick, NJ
- Active Since 06/04/2006
- Last Updated 10/29/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1619915246
Products in Payments
- THYMOGLOBULIN (Drug) $5,071
- MENQUADFI (Biological) $1,448
- NULOJIX (Biological) $875.00
- ZOLGENSMA (Biological) $657.00
- TARPEYO (Drug) $100.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in New Brunswick
Richard Drachtman
Pediatrics — Payments: $257,824
Dr. Niketa Shah, Md, MD
Pediatrics — Payments: $49,820
Ahmed Khattab, Md, MD
Pediatrics — Payments: $26,038
Dr. Priti Sharma, M.d, M.D
Pediatrics — Payments: $1,324
Milen Velinov, Md Phd, MD PHD
Pediatrics — Payments: $1,089
Vineeta Mittal, M.d, M.D
Pediatrics — Payments: $895.43